Evidence map›Paper›PMID 35444646›Full record

ArticleFrontiers in immunology2022

Decreased CD73+ Double-Negative T Cells and Elevated Level of Soluble CD73 Correlated With and Predicted Poor Immune Reconstitution in HIV-Infected Patients After Antiretroviral Therapy.

Xinyue Wang, Leidan Zhang, Juan Du, Yuqing Wei, Di Wang, Chuan Song, Danying Chen, Bei Li, Meiqing Jiang, Mengyuan Zhang and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Increased CD95Frontiers in immunology · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Elevated Foxp3Frontiers in immunology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Xinyue WangPeking University Ditan Teaching Hospital, Beijing, China.
Leidan ZhangPeking University Ditan Teaching Hospital, Beijing, China.
Juan DuBeijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Yuqing WeiBeijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Di WangNational Center for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Chuan SongBeijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Danying ChenBeijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Bei LiNational Center for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Meiqing JiangBeijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Mengyuan ZhangBeijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Hongxin ZhaoNational Center for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Yaxian KongPeking University Ditan Teaching Hospital, Beijing, China.
Beijing Ditan Hospital · CNNational Institute for Communicable Disease Control and Prevention · CNCapital Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although extensive use of antiretroviral therapy (ART) has made great progress in controlling HIV replication and improving CD4

Indexed as

HIV InfectionsImmune ReconstitutionCD4-CD8 RatioCD4-Positive T-LymphocytesHumansCD73double-negative T cellHIVimmune activationimmune reconstitution

Identifiers

PMID35444646
PMCPMC9013806
OpenAlexW4226137924

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.